John Hart to Risk Assessment
This is a "connection" page, showing publications John Hart has written about Risk Assessment.
Connection Strength
0.136
-
Serrated adenoma: a distinct form of non-polypoid colorectal neoplasia? Gastrointest Endosc Clin N Am. 2010 Jul; 20(3):543-63.
Score: 0.047
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.040
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.011
-
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009 Sep; 70(3):417-21.
Score: 0.011
-
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007 Dec; 39(12):1086-91.
Score: 0.010
-
p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease. Dig Dis Sci. 2008 Feb; 53(2):474-80.
Score: 0.010
-
Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause. 2004 Sep-Oct; 11(5):575-7.
Score: 0.008